Modification of Cardiovascular Risk Factors and the Evolution of The Cardiovascular Phenotype of Liver Transplant Recipients in the Long -Term Postoperative Period

Aim. To evaluate the contribution of traditional and additional cardiovascular risk factors (CVRFs) to the development of chronic ischemic heart disease (CIHD) in liver transplant recipients during the long-term postoperative period.
Material and methods. A single-center prospective cohort study was conducted. The study included 740 patients with chronic end-stage liver disease (CESLD) and cirrhotic cardiomyopathy (CCMP). During the observation period (5.4±2.29 years), patients were divided into two groups: liver transplant recipients (n=420) and patients with CESLD on the waiting list who did not receive a donor organ (n=320). In patients enrolled to the study upon inclusion in the waiting list, CVRFs, history, clinical and laboratory and instrumental data were studied at all stages of the hepato-cardiac continuum.
Results. During the long-term postoperative period, liver transplant recipients belonged to the group of high cardiovascular risk: over a 5-year observation period, 35.7% (n=150) of them developed metabolic syndrome (MS), 9.8% developed verified CIHD associated with MS. The incidence of traditional CVRFs was high (arterial hypertension, 88.6%; obesity, 36.6%; hypercholesterolemia, 77.8%; hypertriglyceridemia, 43.6%; reduced concentration of high-density lipoprotein cholesterol, 35.4%; increased concentrations of low-density lipoprotein cholesterol, 66.8% and very low-density lipoprotein cholesterol, 51.2%; increased atherogenic index, 61.5%). During the long-term postoperative period as compared to the period when patients were on the waiting list, additional CVRFs appeared: increases in body mass index, calcium index, nitric oxide metabolites, endothelin-1, homocysteine, intercellular adhesion molecules VCAM-1 and ICAM-1, and decreases in endothelium-dependent vasodilation and glomerular filtration rate to less than 60 ml/min/1.73 m2. A model for the development of CIHD was created. The model uses a complex of independent risk factors and demonstrates a predictive accuracy of 84.6%.
Conclusion. The study results indicate a modification of CVRFs and a dynamic change in the cardiovascular phenotype of liver transplant recipients: progression of CCMP during their stay on the waiting list, regression of CCMP manifestations during the first 12 months after orthotopic liver transplantation, and increases in the total cardiovascular risk and likelihood of CIHD in the long-term postoperative period.

1. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal. 2020;41(2):255–323. DOI: 10.1093/eurheartj/ehz486

2. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Revista Española de Cardiología (English Edition). 2022;75(5):429. DOI: 10.1016/j.rec.2022.04.003

3. Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763–816. DOI: 10.1093/eurheartj/ehx095

4. Kshirsagar AV, Chiu Y, Bomback AS, August PA, Viera AJ, Colindres RE et al. A Hypertension Risk Score for Middle-Aged and Older Adults. The Journal of Clinical Hypertension. 2010;12(10):800–8. DOI: 10.1111/j.1751-7176.2010.00343.x

5. Aghaulor B, VanWagner LB. Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation. Clinics in Liver Disease. 2021;25(1):157–77. DOI: 10.1016/j.cld.2020.08.008

6. Truitt K, Chen K, Yano Y, Gregory DL, VanWagner LB. Blood Pressure Variability Early After Liver Transplantation Predicts Long-Term Mortality. Liver Transplantation. 2022;28(4):615–22. DOI: 10.1002/lt.26370

7. Sharma V, Kleb C, Sheth C, Verma BR, Jain V, Sharma R et al. Cardiac considerations in liver transplantation. Cleveland Clinic Journal of Medicine. 2022;89(1):46–55. DOI: 10.3949/ccjm.89a.21006

8. Plotogea O, Ilie M, Sandru V, Chiotoroiu A, Bratu O, Diaconu C. Cardiovascular and Metabolic Consequences of Liver Transplantation: A Review. Medicina. 2019;55(8):489. DOI: 10.3390/medicina55080489

9. De Luca L, Kalafateli M, Bianchi S, Alasaker N, Buzzetti E, Rodríguez-Perálvarez M et al. Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors. Liver International. 2019;39(8):1557–65. DOI: 10.1111/liv.14185

10. Mohebali D, Anagnostopoulos A-M, Estrada-Roman A, Pavlakis M, Curry MP, Gavin MC. Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional Standardized Approach. Cardiology in Review. 2019;27(6):286–92. DOI: 10.1097/CRD.0000000000000282

11. Nemes K, Åberg F, Gylling H, Isoniemi H. Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications. World Journal of Hepatology. 2016;8(22):924–32. DOI: 10.4254/wjh.v8.i22.924

12. Gallegos-Orozco JF, Charlton MR. Predictors of Cardiovascular Events After Liver Transplantation. Clinics in Liver Disease. 2017;21(2):367–79. DOI: 10.1016/j.cld.2016.12.009

13. Grigorenko E.A., Shalimova A.S., Rummo O.O., Mitkovskaya N.P. Dyslipidemia in liver transplant recipients. Emergency Cardiology and Cardiovascular Risks. 2021;5(2):1270–3. DOI: 10.51922/2616-633X.2021.5.2.1265

14. Ministry of Health of the Republic of Belarus. Order No. 6 dated 05.01.2010 ‘On approval of certain protocols for transplantation of human organs and tissues’. Av. at: https://minzdrav.gov.by/upload/dadvfiles/CProtokol/КП трансплантации печени 05.01.2010 № 6.pdf?ysclid=lqt4l13lmh745614048.